All conditions

Depression and Anxiety

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

70
Trials tracked
0
Recruiting now
15
Australian sites
54
Countries

If you need support right now

  • Lifeline (24/7 crisis support)13 11 14
  • Beyond Blue1300 22 4636
  • SANE Australia1800 187 263
  • Suicide Call Back Service1300 659 467
  • Emergency — 000
Country

Showing 70 trials

🇦🇺 AU site

Trial: NCT06143293 — University of Minnesota

NCT06143293 · University of Minnesota
Active, Not Recruiting Not Applicable Est. completion 31 August 2026
🇦🇺 AU 🇺🇸 US

Who might be able to join this trial: **For people with depression who already have a VNS (nerve stimulator) device implanted (Group 1a):** - You must be at least 18 years old. - You must be able to understand and sign a consent form agree...

🇦🇺 AU site

Trial: NCT00738634 — Australian National University

NCT00738634 · Australian National University
Completed Not Applicable Est. completion 1 April 2010
🇦🇺 AU

Who might be able to join this trial: - The trial is open to teenagers who are currently in Grades 7 to 10 (high school) and their parents or guardians. - Teenagers who score in the middle range (between 14 and 30) on a standard depression...

🇦🇺 AU site

Trial: NCT01031186 — GlaxoSmithKline

NCT01031186 · GlaxoSmithKline
Completed Phase 1 Est. completion 7 April 2010
🇦🇺 AU

**Who might be able to join this trial:** - Your liver function blood test results (AST, ALT, alkaline phosphate, and bilirubin) must be at or below 1.5 times the normal upper limit. - You must be considered healthy by an experienced doctor...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00436020 — Bayside Health

NCT00436020 · Bayside Health
Completed Not Applicable Est. completion 1 June 2015
🇦🇺 AU

Who might be able to join this trial: - You have been diagnosed with bipolar disorder (type I or II) and are currently going through a major depressive episode. - You are between 18 and 70 years old. - Your depressive symptoms have lasted f...

🇦🇺 AU site

Trial: NCT01002027 — University of Melbourne

NCT01002027 · University of Melbourne
Completed Not Applicable Est. completion 1 February 2007
🇦🇺 AU

Who might be able to join this trial: - Women who speak English and are 3 months after giving birth Who may not be able to join: - Women who have a condition involving a loss of touch with reality, such as hallucinations or delusions (conf...

🇦🇺 AU site

Trial: NCT03496675 — NORCE Norwegian Research Centre AS

NCT03496675 · NORCE Norwegian Research Centre AS
Completed Not Applicable Est. completion 29 September 2023
🇦🇺 AU 🇩🇪 DE 🇳🇱 NL 🇳🇴 NO Turkey (Türkiye)

Who might be able to join this trial: - You must be living full-time (24 hours a day) in one of the care homes taking part in the study. - You must have dementia, confirmed by specific memory and thinking tests showing at least mild impairm...

🇦🇺 AU site

Trial: NCT00789854 — AstraZeneca

NCT00789854 · AstraZeneca
Completed Phase 3 Est. completion 1 August 2009
🇦🇺 AU 🇦🇹 AT 🇧🇪 BE 🇧🇬 BG 🇩🇰 DK

**Who might be able to join this trial:** - You have been officially diagnosed with Major Depressive Disorder (MDD) — either a single episode or a recurring episode — confirmed using a standard diagnostic interview tool - Your current episo...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00599911 — H. Lundbeck A/S

NCT00599911 · H. Lundbeck A/S
Completed Phase 2 Est. completion 1 March 2009
🇦🇺 AU 🇦🇹 AT 🇧🇪 BE 🇨🇦 CA 🇨🇿 CZ

Who might be able to join this trial: - You have been experiencing a major depressive episode that has lasted at least 3 months - Your depression is moderate to severe in intensity Who may not be able to join: - You currently have a primar...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00869765 — The University of New South Wales

NCT00869765 · The University of New South Wales
Completed Phase 2 Est. completion 1 September 2010
🇦🇺 AU

**Who might be able to join this trial:** - You previously took part in a specific earlier study (called HREC 07305), which tested a brain stimulation treatment for depression, and you completed that study fully. - At the end of that earlie...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01849367 — The University of New South Wales

NCT01849367 · The University of New South Wales
Completed Phase 2 Est. completion 1 July 2015
🇦🇺 AU

**Who might be able to join this trial:** - You have been diagnosed with a Major Depressive Episode according to standard psychiatric guidelines (DSM-IV). - Your depression has been rated as moderately severe or worse, based on a standard s...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT07247370 — South West Sydney Local Health District

NCT07247370 · South West Sydney Local Health District
Not Yet Recruiting Phase 2 Est. completion 10 April 2027
🇦🇺 AU

**Who might be able to join this trial:** - You have been diagnosed with moderate to severe alcohol use disorder (AUD) based on standard psychiatric guidelines (DSM-5) - You currently have a diagnosis of Major Depressive Disorder (MDD) bas...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT05518149 — Janssen Research & Development, LLC

NCT05518149 · Janssen Research & Development, LLC
Terminated Phase 3 Est. completion 25 April 2025
🇦🇷 AR 🇦🇺 AU 🇧🇪 BE 🇧🇷 BR 🇧🇬 BG

**Who might be able to join this trial:** *If you are joining from a previous related study (transferred-entry):* - You must have fully completed the treatment phase of one of two specific earlier studies (67953964MDD3001 or 67953964MDD300...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT04352634 — University of Chile

NCT04352634 · University of Chile
UNKNOWN Not Applicable Est. completion 31 December 2021
🇦🇷 AR Armenia 🇦🇺 AU Bolivia 🇨🇱 CL

Who might be able to join this trial: - You must be of legal adult age. - You must currently be working in a healthcare setting that provides care to COVID-19 patients. - You must be willing to give your informed consent to take part in the...

🇦🇺 AU site

Trial: NCT04377412 — Żelazna Medical Centre, LLC

NCT04377412 · Żelazna Medical Centre, LLC
UNKNOWN Not Applicable Est. completion 31 August 2020
Albania 🇦🇺 AU 🇨🇿 CZ 🇫🇷 FR 🇩🇪 DE

Who might be able to join this trial: - You are currently pregnant. - You are able to complete the survey in one of the languages it is offered in. - You are able to answer the screening questions provided. - You are willing to give your co...

🇦🇺 AU site

Trial: NCT00470639 — The University of New South Wales

NCT00470639 · The University of New South Wales
Withdrawn Phase 2 Est. completion 1 December 2008
🇦🇺 AU

**Who might be able to join this trial:** - You have been diagnosed with a major depressive episode that has lasted no more than 3 years. - You have been diagnosed with bipolar disorder type I or type II. - Your depression has been measured...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT05424224 — Florida International University

NCT05424224 · Florida International University
Active, Not Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with depression by a doctor - You are willing to participate and cooperate with the study procedures Who may not be able to join: - You have an implanted electronic device in...

Trial: NCT07493369 — Southern Methodist University

NCT07493369 · Southern Methodist University
Active, Not Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - You prefer to receive therapy in Spanish - You have low positive mood, plus signs of depression, anxiety, or stress, based on specific questionnaire scores, and these feelings are affecting your d...

Trial: NCT05273996 — David Steffens

NCT05273996 · David Steffens
Active, Not Recruiting Phase 4 Est. completion 30 April 2027
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with major depression, either as a single episode or as something that has come back more than once. - You are able to read and write in English. - You scored above 25 on a sta...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00122083 — University of Oxford

NCT00122083 · University of Oxford
Completed Not Applicable
🇬🇧 GB

Who might be able to join this trial: - You are currently an undergraduate student at Oxford University Who may not be able to join: - You are a postgraduate student at Oxford University - You are a student at one of the colleges that have...

Trial: NCT00247429 — Wyeth is now a wholly owned subsidiary of Pfizer

NCT00247429 · Wyeth is now a wholly owned subsidiary of Pfizer
Completed Not Applicable Est. completion 1 October 2005

Who might be able to join this trial: - You are older than 60 years of age - You are experiencing symptoms of depression along with anxiety, measured as moderate or severe on a standard depression rating scale (confirm with trial site) Who...

Trial: NCT01952366 — Sykehuset Innlandet HF

NCT01952366 · Sykehuset Innlandet HF
Completed Not Applicable Est. completion 1 January 2013
🇳🇴 NO

Who might be able to join this trial: - You have been diagnosed with depression and have been referred to specialist healthcare in Norway. - You are over 60 years old. Who may not be able to join: - You have dementia along with severe diff...

Trial: NCT02308956 — University of Cape Town

NCT02308956 · University of Cape Town
Completed Phase 3 Est. completion 16 May 2017
Ethiopia

**Who might be able to join this trial:** - You must be a current participant in the ongoing Butajira SMD cohort study (people originally enrolled between 1998 and 2001 who were aged 15–49, living in the area, and diagnosed with schizophre...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT04476446 — Janssen-Cilag, S.A.

NCT04476446 · Janssen-Cilag, S.A.
Completed Phase 3 Est. completion 16 June 2023
🇲🇽 MX

**Who might be able to join this trial:** - You have treatment-resistant depression (depression that has not improved with other treatments) and there are no other available treatment options, including no suitable clinical trials nearby o...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT05952713 — Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

NCT05952713 · Mental Health Centre Copenhagen, Bispebjerg and Fr...
Completed Not Applicable Est. completion 1 July 2023
🇩🇰 DK

Who might be able to join this trial: - You had contact with psychiatric services (either as a hospital inpatient or as an outpatient) at some point between 1995 and 2018 - Your first main psychiatric diagnosis during that time was a single...

Trial: NCT00014482 — Memorial Sloan Kettering Cancer Center

NCT00014482 · Memorial Sloan Kettering Cancer Center
Completed Not Applicable Est. completion 1 March 2003
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with a blood cancer (such as lymphoma or myeloma) - You are aged 18 or older - You are planning to have high-dose treatment followed by a stem cell transplant using your ow...

Trial: NCT03645096 — University of Texas Southwestern Medical Center

NCT03645096 · University of Texas Southwestern Medical Center
Completed Phase 1 Est. completion 31 May 2022
🇺🇸 US

**Who might be able to join this trial:** - You are a woman between the ages of 18 and 65 years old - You have been diagnosed with mild or moderate major depression (MDD) based on a structured clinical interview - You have not taken any psy...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT01185561 — Loyola University

NCT01185561 · Loyola University
Completed Not Applicable Est. completion 1 November 2009
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have been diagnosed with type 2 diabetes for more than six months and are receiving medical treatment for it - You score 16 or higher on a depression symp...

Trial: NCT02615483 — Central Jutland Regional Hospital

NCT02615483 · Central Jutland Regional Hospital
Completed Not Applicable Est. completion 1 August 2018
🇩🇰 DK

Who might be able to join this trial: - You are planning to have a lumbar spinal fusion surgery involving one, two, or three levels of your lower spine, with hardware (such as screws or rods) used during the procedure. Who may not be able...

Trial: NCT05464550 — Centre Hospitalier Henri Laborit

NCT05464550 · Centre Hospitalier Henri Laborit
Completed Not Applicable Est. completion 15 June 2022
🇫🇷 FR

Who might be able to join this trial: - You have been diagnosed with a depressive disorder according to recognised medical guidelines (DSM-V) - You are a man or woman between 18 and 60 years old - You do not have any mental impairment that...

Trial: NCT00227942 — Hadine Joffe, MD

NCT00227942 · Hadine Joffe, MD
Completed Phase 4
🇺🇸 US

**Who might be able to join this trial:** - You are going through or have already been through menopause (either naturally or due to surgery) - If you had surgery to remove your uterus but kept one or both ovaries, you may still qualify if...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT07292064 — Gulseren Demir Karakilic

NCT07292064 · Gulseren Demir Karakilic
Completed Not Applicable Est. completion 30 June 2025
Turkey (Türkiye)

Who might be able to join this trial: - You are between 18 and 65 years old - You are able to read and write - You have no problems with memory, thinking, or understanding - You have been diagnosed with a temporomandibular joint disorder (a...

Trial: NCT02790398 — Universitat Jaume I

NCT02790398 · Universitat Jaume I
Completed Not Applicable Est. completion 1 March 2016
🇪🇸 ES

**Who might be able to join this trial:** - You are 18 years old or older - You have been diagnosed with one of the following mental health conditions: major depression, dysthymia (long-term low-level depression), generalized anxiety disord...

Trial: NCT05681793 — Hopital Nord Franche-Comte

NCT05681793 · Hopital Nord Franche-Comte
Completed Not Applicable Est. completion 2 March 2023
🇫🇷 FR

Who might be able to join this trial: - You are 75 years old or older - You are currently receiving treatment at a day hospital or oncology week hospital - You have been informed about the trial and have not said no to taking part Who may...

Trial: NCT00366652 — Wyeth is now a wholly owned subsidiary of Pfizer

NCT00366652 · Wyeth is now a wholly owned subsidiary of Pfizer
Completed Phase 3
🇺🇸 US

Who might be able to join this trial: - You are a man or woman between 18 and 55 years old - You are considered healthy based on your medical history, a physical exam, blood/lab tests, vital signs (like blood pressure and heart rate), and a...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00972634 — Norwegian University of Science and Technology

NCT00972634 · Norwegian University of Science and Technology
Completed Not Applicable Est. completion 1 November 2009
🇳🇴 NO

"Who might be able to join this trial: - You have been diagnosed with a cancer that cannot be cured, including if you are currently receiving treatment to help prolong your life. - Your cancer has spread to other parts of the body and/or ha...

Trial: NCT03268434 — Universitätsklinikum Hamburg-Eppendorf

NCT03268434 · Universitätsklinikum Hamburg-Eppendorf
Completed Not Applicable Est. completion 22 August 2019
🇩🇪 DE

Who might be able to join this trial: - You are willing and able to give your informed consent to take part in the study. - You are between 18 and 70 years old. - You have been diagnosed with major depressive disorder (either a single episo...

Trial: NCT04630964 — Section for Affective Disorders; Northern Stockholm Psychiatry

NCT04630964 · Section for Affective Disorders; Northern Stockhol...
Completed Phase 2 Est. completion 19 April 2023
🇸🇪 SE

**Who might be able to join this trial:** - You are between 20 and 65 years old at the time of signing the consent form - You can read, speak, and understand Swedish - You are willing and able to follow all study requirements, including at...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT04923204 — AB Biotics, SA

NCT04923204 · AB Biotics, SA
Completed Not Applicable Est. completion 31 March 2016
🇪🇸 ES

Who might be able to join this trial: - You must be 18 years of age or older - You must have been diagnosed with bipolar disorder and currently be experiencing a depressive episode, which may or may not include symptoms such as hallucinatio...

Trial: NCT01571011 — Benjamin Van Voorhees, MD, MPH

NCT01571011 · Benjamin Van Voorhees, MD, MPH
Completed Not Applicable Est. completion 1 April 2014
🇺🇸 US

**Who might be able to join this trial:** - African American or Latino/a young people (male or female) between the ages of 13 and 17 - Teenagers who have been feeling depressed for more than 2 weeks, but whose symptoms have not yet reached...

Trial: NCT01147614 — San Diego State University

NCT01147614 · San Diego State University
Completed Not Applicable Est. completion 1 April 2016
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with, or likely have, one of the following conditions: Separation Anxiety Disorder, Generalized Anxiety Disorder, Social Phobia, Major Depression, Dysthymic Disorder, or Minor...

Trial: NCT04728958 — University of Sheffield

NCT04728958 · University of Sheffield
Completed Not Applicable Est. completion 28 February 2022
🇬🇧 GB

Who might be able to join this trial: - You work in a healthcare setting (in any role, whether clinical or non-clinical) during the COVID-19 pandemic - You have a basic understanding of English Who may not be able to join: - You are curren...

Trial: NCT00004554 — University of Pennsylvania

NCT00004554 · University of Pennsylvania
Completed Phase 4 Est. completion 1 August 2005
🇺🇸 US

**Who might be able to join this trial:** - You are a man or woman between 18 and 75 years old who is seen as an outpatient (not staying overnight in a hospital). - You have been diagnosed with a major depressive episode (either on its own...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT05988502 — Far Eastern Memorial Hospital

NCT05988502 · Far Eastern Memorial Hospital
Completed Not Applicable Est. completion 30 October 2022
🇹🇼 TW

**Who might be able to join this trial:** - Your heart condition is mild to moderate, meaning you can do some daily activities but may feel symptoms with exertion (this is based on a heart function rating scale called NYHA classes I–III) -...

Trial: NCT06083272 — VitalThings

NCT06083272 · VitalThings
Completed Not Applicable Est. completion 28 November 2023
🇳🇴 NO

Who might be able to join this trial: - You must be an adult (18 years or older) who has been admitted to the Emergency Ward - You must be able to give your own consent to take part in the study Who may not be able to join: - People under...

Trial: NCT01715805 — Forest Laboratories

NCT01715805 · Forest Laboratories
Completed Phase 3 Est. completion 24 June 2016
Puerto Rico 🇺🇸 US

Who might be able to join this trial: - You have given your written agreement to take part before any trial procedures begin - You have been diagnosed with Major Depressive Disorder (a serious form of depression) according to a standard set...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT03438656 — University of Washington

NCT03438656 · University of Washington
Completed Not Applicable Est. completion 31 March 2023
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with depression (either minor or major depression) — this trial is for the Behavioral Activation treatment group **Who may not be able to join:** - Your child has an IQ be...

Trial: NCT02731053 — Université de Montréal

NCT02731053 · Université de Montréal
Completed Phase 4 Est. completion 1 November 2016
🇨🇦 CA

Who might be able to join this trial: - You have a higher-than-usual level of depressive symptoms, shown by scoring 20 or above on a standard depression questionnaire called the CES-D Who may not be able to join: - You have already been di...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT06407154 — Universitätsklinikum Hamburg-Eppendorf

NCT06407154 · Universitätsklinikum Hamburg-Eppendorf
Completed Not Applicable Est. completion 19 September 2024
🇩🇪 DE

Who might be able to join this trial: - You are 18 years old or older - You have been diagnosed with at least one of the following conditions: coronary heart disease, heart attack, heart failure, irregular heartbeat, blocked arteries in the...

Trial: NCT06295185 — Ajou University School of Medicine

NCT06295185 · Ajou University School of Medicine
Completed Not Applicable Est. completion 31 July 2024
🇰🇷 KR

**Who might be able to join this trial:** - You must be an employee at a HISBEANS store - You must be 18 years old or older - You must own a smartphone with an internet connection - You must agree to take part in the study **Who may not be...

Trial: NCT01886586 — University of Pittsburgh

NCT01886586 · University of Pittsburgh
Completed Not Applicable Est. completion 1 June 2016
🇺🇸 US

**Who might be able to join this trial:** *For the person with memory/thinking concerns (MCI participant):* - You are age 60 or older - You score 80 or above on a standard memory and thinking test called the Modified Mini Mental State exam...

Trial: NCT02861755 — Northwestern University

NCT02861755 · Northwestern University
Completed Not Applicable Est. completion 1 August 2018
🇺🇸 US

Who might be able to join this trial: - You have access to the internet every day - You own a cell phone - You scored 5 or higher on a depression screening questionnaire called the PHQ-8 (confirm with trial site) - You currently live in the...

Trial: NCT04666662 — University of York

NCT04666662 · University of York
Completed Not Applicable Est. completion 24 June 2024
🇬🇧 GB

Who might be able to join this trial: - You have had depression in the past but are currently in a period of recovery (remission), meaning your symptoms have improved or gone away. Who may not be able to join: - You are currently living wi...

Trial: NCT04592588 — University of Pennsylvania

NCT04592588 · University of Pennsylvania
Completed Not Applicable Est. completion 30 August 2021
🇮🇳 IN

Who might be able to join this trial: - You are at least 18 years old - You are currently a student at a participating university in India Who may not be able to join: - No specific exclusion criteria were listed for this trial (confirm wi...

Trial: NCT01195740 — Children's Hospital of Philadelphia

NCT01195740 · Children's Hospital of Philadelphia
Completed Phase 2 Est. completion 1 November 2011
🇺🇸 US

Who might be able to join this trial: - You are currently receiving inpatient mental health treatment - You have made a suicide attempt within the past month - You have a main caregiver (such as a parent or guardian) who is willing to take...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02300584 — Emory University

NCT02300584 · Emory University
Completed Not Applicable Est. completion 1 October 2015
🇺🇸 US

Who might be able to join this trial: - You are an unpaid, informal caregiver for someone who has a dementia-related condition, such as Alzheimer's disease - You can speak, read, and understand English - You have access to a computer with a...

Trial: NCT02357680 — Hospitalsenheden Vest

NCT02357680 · Hospitalsenheden Vest
Completed Not Applicable Est. completion 31 October 2017
🇩🇰 DK

**Who might be able to join this trial:** - You are expected to stay in the intensive care unit (ICU) for more than 48 hours - You are expected to need a breathing machine (ventilator) for more than 24 hours - You have a close family member...

Trial: NCT02387424 — University of Colorado, Boulder

NCT02387424 · University of Colorado, Boulder
Completed Not Applicable Est. completion 1 May 2013
🇺🇸 US

**Who might be able to join this trial:** - You are pregnant and at no more than 32 weeks along in your pregnancy - You have had depression in the past (meeting certain medical criteria for it) - You have not been diagnosed with active majo...

Trial: NCT02790970 — P1vital Products Limited

NCT02790970 · P1vital Products Limited
Completed Not Applicable Est. completion 30 November 2018
🇫🇷 FR 🇩🇪 DE 🇳🇱 NL 🇪🇸 ES 🇬🇧 GB

**Who might be able to join this trial:** - You are a male or female aged between 18 and 70 years old (inclusive). - You have been diagnosed by a doctor with a depressive episode (either your first episode or a returning one) that needs to...

Trial: NCT05136742 — Cairo University

NCT05136742 · Cairo University
Completed Not Applicable Est. completion 1 December 2022
🇪🇬 EG

**Who might be able to join this trial:** - You are a woman between 55 and 65 years old who has gone through menopause - Your menopause started more than 2 years ago - Your body mass index (BMI) — a measure of body weight relative to height...

Trial: NCT00001483 — National Institute of Mental Health (NIMH)

NCT00001483 · National Institute of Mental Health (NIMH)
Completed Phase 2
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with Bipolar I disorder, Bipolar II disorder, Bipolar disorder not otherwise specified, or schizoaffective disorder (bipolar type). - You are able to understand the purpose of...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT03060096 — Wake Forest University Health Sciences

NCT03060096 · Wake Forest University Health Sciences
Completed Not Applicable Est. completion 29 July 2022
🇺🇸 US

Who might be able to join this trial: - You are 18 years old or older - You have scored 10 or higher on the GAD-7 anxiety questionnaire and/or 8 or higher on the PHQ-9 depression questionnaire, suggesting significant anxiety or depression s...

Trial: NCT02178696 — University of Michigan

NCT02178696 · University of Michigan
Completed Phase 4 Est. completion 1 October 2015
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with Major Depressive Disorder (a condition involving persistent feelings of sadness or low mood) - Your depression has been measured as moderate to severe using a standard...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02194036 — Helse Nord-Trøndelag HF

NCT02194036 · Helse Nord-Trøndelag HF
Completed Not Applicable Est. completion 1 September 2017
🇳🇴 NO

Who might be able to join this trial: - You are 18 years of age or older - You are able to read, write, and speak Norwegian - You are able to understand the information about the study and give your consent to take part - You have been refe...

Trial: NCT05262621 — The Nethersole School of Nursing

NCT05262621 · The Nethersole School of Nursing
Completed Not Applicable Est. completion 2 August 2022
🇻🇳 VN

**Who might be able to join this trial:** - You are a woman aged 18 or older who has been diagnosed with breast or gynaecological (reproductive system) cancer - You live with family and have at least one adult family member who agrees to ta...

Trial: NCT00595699 — Conrad, Erich J., M.D.

NCT00595699 · Conrad, Erich J., M.D.
Completed Phase 4 Est. completion 1 December 2009
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with temporal lobe epilepsy. - You have been diagnosed with Major Depression (based on standard medical criteria called DSM-IV). - Your depression score on a standard ratin...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00070941 — NYU Langone Health

NCT00070941 · NYU Langone Health
Completed Phase 3 Est. completion 1 June 2010
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with Parkinson's disease and show at least two of these signs: shaking at rest, muscle stiffness, slowness of movement, or balance problems - Your Parkinson's medications h...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00621842 — University Hospitals Cleveland Medical Center

NCT00621842 · University Hospitals Cleveland Medical Center
Completed Phase 3 Est. completion 1 March 2010
🇺🇸 US

**Who might be able to join this trial:** - You are 60 years of age or older - You have been diagnosed with Bipolar Disorder (Type I or Type II) and are currently experiencing a depressive episode - You have scored above 18 on a standard de...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02158546 — Alkermes, Inc.

NCT02158546 · Alkermes, Inc.
Completed Phase 3 Est. completion 1 December 2015
🇧🇬 BG 🇺🇸 US

**Who might be able to join this trial:** - Your body weight falls within a healthy to moderately overweight range (BMI between 18.0 and 40.0) - You are willing to use an accepted form of birth control for the whole length of the study - Yo...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02600754 — University of Texas at Austin

NCT02600754 · University of Texas at Austin
Completed Not Applicable Est. completion 1 December 2020
🇺🇸 US

Who might be able to join this trial: - You have a score above 14 on a standard depression rating scale called the HAMD (confirm with trial site) - You are 50 years old or older - You speak English or Spanish - You identify as Non-Hispanic...

Trial: NCT00026052 — National Institute of Mental Health (NIMH)

NCT00026052 · National Institute of Mental Health (NIMH)
Completed Phase 2
🇺🇸 US

Who might be able to join this trial: - You are between 18 and 70 years old (male or female) - If you are a woman who could become pregnant, you are using an accepted form of birth control - You are able to understand and agree to all the t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)